blue gloved hand putting vial of blood into machine
Studies Identify Risk Factors for Long COVID
Two recent papers provide insight into possible risk factors for developing the chronic condition, including autoantibodies and diabetes.
ABOVE: © ISTOCK.COM, baranozdemir
Studies Identify Risk Factors for Long COVID
Studies Identify Risk Factors for Long COVID

Two recent papers provide insight into possible risk factors for developing the chronic condition, including autoantibodies and diabetes.

Two recent papers provide insight into possible risk factors for developing the chronic condition, including autoantibodies and diabetes.

ABOVE: © ISTOCK.COM, baranozdemir

antibodies

a blood bag partially full of yellow liquid
Convalescent Plasma for COVID-19 Cuts Hospitalizations: Preprint
Shawna Williams | Dec 21, 2021
Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.
orange and blue cell image
Woman’s Body Appears to Rid Itself of HIV
Chloe Tenn | Nov 18, 2021
Researchers report what appears to be the second case of a person’s immune system clearing the virus on its own.
chipcytometry-tissue
Revolutionizing Cellular Phenotyping with Multiplex Tissue Imaging
The Scientist Creative Services Team, Canopy Biosciences | May 9, 2022
Highly multiplexed tissue immunohistochemistry combined with an automated, high resolution imaging pipeline resolves unlimited protein targets in intact tissue.  
illustration of people of different genders and races
Does Biological Sex Influence COVID-19 Outcomes?
Annie Melchor | Nov 2, 2021
It’s unclear whether differing odds of dying between men and women reflect inherent differences between male and female immune systems or differences rooted in gender norms.
illustration of a coronavirus and antibodies
When the Immune Response Makes COVID-19 Worse
Alejandra Manjarrez | Sep 27, 2021
If the immune system makes mistakes—reacting late or getting the target wrong—it can amplify the damage wrought by SARS-CoV-2.
An Improved Way to Detect CAR T Cells and SARS-CoV-2-Binding Cells
Technique Talk: An Improved Way to Detect CAR T Cells and SARS-CoV-2-Binding Cells
The Scientist Creative Services Team, Bio-Techne | Apr 13, 2022
Jody Bonnevier will discuss the advantages of Fluorokines™ for detecting and investigating CAR T cells and other key drivers of the immune system.
moderna and pfizer vaccine vials
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Alejandra Manjarrez | Sep 24, 2021
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna’s elicits a stronger immune response and might be better at preventing breakthrough infections.  
Updated Mar 8
A healthcare worker holds up three syringes with clear medicine
To Booster or Not: Scientists and Regulators Debate
Jef Akst | Sep 16, 2021
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
Recombinant proteins have a wide range of research and clinical applications.
Introducing Custom Recombinant Expression Services at the Cutting Edge of Biomolecular Engineering
The Scientist Creative Services Team, Sino Biological | Mar 24, 2022
A turnkey CRO service platform for recombinant protein and antibody expression and production
A grayscale electron micrograph shows hundreds of sperm cells stuck together in the foreground
Antibodies Stop Sperm in Their Tracks
Abby Olena | Aug 11, 2021
Engineered antibodies trap and immobilize human sperm in the reproductive tract of female sheep, paving the way for possible use as a nonhormonal contraceptive in people.
a pink and purple micrograph of a longitudinal section of human spinal ganglion cells
Mouse Study Suggests Fibromyalgia Has Autoimmune Roots
Annie Melchor | Jul 2, 2021
When researchers injected mice with antibodies from fibromyalgia patients, the animals developed symptoms of the disease—suggesting that it may be controlled by the immune system, not the nervous system.
Characterizing SARS-CoV-2 Antibody Responses in COVID-19 Patients
Characterizing SARS-CoV-2 Antibody Responses in COVID-19 Patients
The Scientist Creative Services Team, Bio-Techne | Mar 1, 2022
In this webinar, Javier Castillo-Olivares and Matteo Ferrari will discuss what they have learned about COVID-19 through testing patient sera with automated immunoblotting.
Illustration of the BCG vaccine and resulting immune response
Infographic: TB Vaccines in the Pipeline Take Varied Approaches
Anthony King | Jul 1, 2021
More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.  
False-colored micrograph of Mycobacterium tuberculosis
Tuberculosis: The Forgotten Pandemic
Anthony King | Jul 1, 2021
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.
Clear and Easy Flowing: Analyzing Antibody Self-Interactions
Strategies for the Rapid Assessment of Antibody Self-Interactions and Improved Formulations Development
The Scientist Creative Services Team, Sartorius | Feb 2, 2022
Martin Domnowski explains how sequence and formulation affect antibody self-interaction properties, and how researchers detect these interactions in low concentration samples.
close-up of empty vaccine vials in a factory
The Quest for a Universal Coronavirus Vaccine
Diana Kwon | Jun 29, 2021
Scientists are on the hunt for a shot that will protect against not only SARS-CoV-2, but other members of its family that may emerge in the future.
An illustration of several human heads wearing masks
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
Antibodies in breastmilk from SARS-CoV-2 infection or mRNA vaccination neutralize the virus.
Antibodies Against SARS-CoV-2 in Breast Milk Differ Between Vaccinated and Infected Mothers
Roni Dengler, PhD | Dec 6, 2021
All antibodies against SARS-CoV-2 found in breast milk neutralized the virus.
A vial containing a red blood sample is balanced on its end on a table or desk by someone wearing a blue medical glove on their right hand
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Abby Olena | Jun 17, 2021
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.